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MesenchymeBranching morphogenesis in murine submandibular glands (SMG) is regulated by growth factors,
extracellular matrix (ECM) and many biological processes through interactions between the epithelium
and the mesenchyme. MicroRNAs (miRNAs) are a set of small, non-protein-coding RNAs that regulate gene
expression at the post-transcriptional level. We hypothesized that branching morphogenesis is partly
regulated by miRNAs. Forty-four miRNAs and novel miRNA candidates were detected in SMG at embryonic
day 13 by a cloning method combined with Argonaute-2 immunoprecipitation. MicroRNA21 (miR-21)
expression in the mesenchyme was up-regulated and accelerated by epidermal growth factor, which is
known to enhance branching morphogenesis in vitro. Down-regulation of miR-21 in the mesenchyme by
locked nucleic acids was associated with a decrease in the number of epithelial buds. Relative quantiﬁcation of
candidates for target genes of miR-21 indicated that two messenger RNAs (for Reck and Pdcd4) were down-
regulated in the mesenchyme, where miR-21 expression levels were up-regulated. These results suggest that
branching morphogenesis is regulated by miR-21 through gene expression related to ECM degradation in the
mesenchyme.himata).
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
MicroRNAs (miRNAs) are 19–24 nt endogenous RNA products of
non-coding genes and are present in all multicellular organisms
(Bartel, 2009; Kim et al., 2009). It is known that miRNAs triggering
RNA silencing are generated from endogenous hairpin-shaped
transcripts and are loaded onto a member of the Argonaute (Ago)
family of proteins (Kim et al., 2009). RNA silencing by miRNAs occurs
through cleavage of RNA, degradation of messenger RNAs (mRNAs) or
suppression of mRNA translation (Bartel, 2009; Kim et al., 2009). Most
miRNAs show tissue-speciﬁc or developmental stage-speciﬁc expres-
sion and are involved in cell differentiation and developmental
transitions. It is known that miRNAs recognize target mRNAs based on
seed region, and bind to partially complementary sites, usually in the
3′ untranslated region of mRNAs (Bartel, 2009). It is estimated that, on
average, each miRNA can target 200 different transcripts (Lewis et al.,
2005). Since there is just partial complementarity between miRNAs
and their targets in animal cells, the identiﬁcation of speciﬁc target
genes for a given miRNA remains a major challenge in our
understanding of miRNA function (Bartel, 2009). Recently, it was
reported that target mRNAs tended to be present at low expression
levels in domains expressing the cognate miRNAs (Farh et al., 2005;
Lim et al., 2005; Sood et al., 2006; Stark et al., 2005). This resulted inquantitatively complementary expression patterns between miRNAs
and their targets, leading to postulation of a “mutual exclusionmodel”
of miRNA regulation of gene expression (Bushati and Cohen 2007;
Stark et al., 2005).
The fetal murine submandibular salivary gland (SMG) is a well
analyzed model system for studying organogenesis, including
branching morphogenesis. Branching morphogenesis is a basic
developmental process in the formation of many organs, such as
exocrine glands, the lung and the kidney. In addition, this process is
known to be dependent on reciprocal epitheliomesenchymal inter-
actions (Bernﬁeld et al., 1984; Birchmeier and Birchmeier, 1993;
Hogan, 1999; Lu andWerb, 2008; Metzger and Krasnow, 1999) and in
part on the ErbB family of tyrosine kinase receptors and some of the
ligands that activate them (Jaskoll and Melnick, 1999; Kashimata and
Gresik, 1997; Koyama et al., 2008; Larsen et al., 2003; Miyazaki et al.,
2004; Morita and Nogawa, 1999; Nogawa and Takahashi, 1991;
Umeda et al., 2001). Epidermal growth factor (EGF) is one of the
ligands for the ErbB family, and it has been shown to stimulate
branching morphogenesis (Kashimata and Gresik, 1997; Nogawa and
Takahashi, 1991).
There has been only one report regarding expression of miRNAs in
the SMG (Jevnaker and Osmundsen, 2008). That study was conducted
using microarrays only on embryonic day 15.5 (E15.5) SMGs and on
glands from postnatal days 0, 5 and 25. However, it is on E12.5–13.5
that the epithelium begins branching morphogenesis and forms
approximately 4–5 buds (e.g. Tucker, 2007). These buds continue
branching, resulting in a highly branched gland by E14.5. However,
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branching morphogenesis (i.e. E13).
For this study, we hypothesized that miRNAs can act as important
regulators of developmental events leading to branching morpho-
genesis. We ﬁrst analyzed miRNA expression in E13 SMG using a
cloning method to obtain an expression proﬁle. Then we focused on
one miRNA, miR-21, which was up-regulated during SMG culture, by
analysis using both EGF treatment and RNA interference (RNAi)
methods. This report shows that miR-21 expression in the mesen-
chyme regulates branching morphogenesis in vitro.
Materials and methods
Culture of SMG rudiments
Pregnant, time-mated ICR mice were obtained from SLC, Ltd.
(Shizuoka, Japan). SMG rudiments were isolated from fetuses on the
13th day of gestation (E13, taking the day of discovery of the vaginal
plug as day 0). Dissection of SMG rudiments was performed in DMEM:
F12 serum-free medium with GlutaMAX (GIBCO) by using ﬁne
tweezers under a dissection microscope. For EGF treatment
(20 ng ml−1), E13 SMG rudiments were incubated in 24-well plates
for 0, 6,12 and 24 h in 5% CO2:95% air and 80% humidity at 37 °C in
DMEM:F12 serum-free medium with GlutaMAX that contained
100 units ml−1 penicillin, 100 μg ml−1 streptomycin, 150 μg ml−1
vitamin C and 50 μg ml−1 transferrin (Steinberg et al., 2005).
Transfection of artiﬁcial small RNA
For miR-21 enhancement and inhibition, SMG rudiments were
cultured for 48 h in dishes coated with Matrigel. In brief, a growth
factor-reduced Matrigel (BD Biosciences) was diluted to 5% with the
medium described above, without antibiotics. Glass-bottom dishes
(IWAKI) were coated with the 5% Matrigel and incubated for 1 h at
37 °C in ahumidiﬁed5%CO2/95%air atmosphere for polymerization. Then
SMG rudiments were placed in these dishes with a small amount of
medium(Kadoya andYamashina, 2010). After theﬁrst 24 hof culture, the
medium was changed to the appropriate medium for each experimental
condition.
For miR-21 inhibition, miRCURY LNA microRNA Power Inhibitor for
miR-21 (LNA-21) or Negative Control A (LNA-cont) (Exiqon), and for
enhancement, miRIDIAN microRNA Mimic for miR-21 (MIM-21) or
Negative Control (MIM-control) (Thermo Scientiﬁc), were added to the
medium at 20 nM in the presence of N-TER Nanoparticle siRNA
Transfection System (SIGMA). After 24 h the medium was replaced
with medium containing artiﬁcial RNA and transfection reagent. As
controls, SMG rudiments were treated with transfection reagent only
(without artiﬁcial RNA, i.e. RNA(−)) to compare with SMG rudiments
cultured with only medium (without any RNA or transfection reagent).
The numbers of branches formedwere compared by a one-tailed t-test to
evaluate the inducing effects of the artiﬁcial RNA and transfection
reagents.
To test for uptake of artiﬁcial RNAs, single-stranded RNA (ssRNA),
Cy3-labeled Anti-miR Negative Control #1 (Ambion) and double-
stranded RNA (dsRNA), Silencer Cy3-labeled Negative Control siRNA
#1 (Ambion) were added to culture medium at 20 nM as described
above. After culture for 24 h, the SMG rudiments were washed three
times with medium to remove residual artiﬁcial RNA and observed by
microscopy (Leica).
Separation of epithelium and mesenchyme
The epithelium and mesenchyme were separated according to the
methods of Carraro et al. (2009). In brief, SMG rudiments from E13
embryos were cultured for 24 h with and without EGF and then
treated with Dispase (5000 units ml−1) (Godo Shusei) for 5 min at4 °C. The SMG rudiments were then transferred to DMEM:F12 serum-
free medium with GlutaMAX (GIBCO) containing 10% fetal bovine
serum (Invitrogen) to block the enzymatic reaction. Epithelium and
mesenchyme were separated in serum-free medium by using ﬁne
tweezers under a microscope (Shimadzu). The separated samples
were immediately transferred to RNAlater (Ambion). RNase-free
phosphate-buffered saline was added to the RNAlater at 1:1, and the
samples were recovered by centrifugation.
RNA extraction and quantiﬁcation by real-time RT-PCR
Total RNA was extracted using TRIzol (Invitrogen) in accordance
with themanufacturer's instructions. The total RNA concentration and
RNA integrity were assessed using the RNA 6000 Pico LabChip Series II
Assay (Agilent Technologies) with an Agilent 2100 bioanalyzer
(Agilent Technologies). The RNA integrity number of all samples in
this report ranged from 8.5 to 10.0. The small RNA concentration was
assessed with an Agilent Small RNA kit (Agilent Technologies) for
real-time RT-PCR of miRNAs.
Cloning analysis
For cloning analysis, the mature miRNA fraction was extracted by
immunoprecipitation using Ago 2 antibody of a microRNA Isolation
kit, Mouse Ago2 (Wako), according to the manufacturer's instruc-
tions. Small RNA fractions including miRNAs were conﬁrmed using an
Agilent Small RNA kit (Agilent Technologies). Subsequently, for
cloning, both 3′-biotinylated linker and 5′ linker RNAs were ligated
to miRNAs, followed by the reverse transcription reaction and
polymerase chain reaction (PCR) using a small RNA Cloning Kit
(TaKaRa). PCR was performed for 15 cycles. The PCR product was run
on a 15% nondenatured polyacrylamide gel at a constant current of
40 mA for 120 min. A band of approximately 65 bp (i.e. the product
with a miRNA between linkers) was cut out of the gel. The gel
fragment was crushed, and the PCR product was eluted using a
Biomasher (Wako). The methods for crushing and elution were as
described in the manufacturer's instructions for the microRNA
Cloning Kit Wako (Wako). A second PCR of 10 cycles was performed
on a 1 μl aliquot of the eluted solution (Watanabe et al., 2007). The
second PCR product was obtained as described above. A single
fragment, approximately 65 bp, was cut out of the gel and cloned with
a TOPO-TA cloning kit (Invitrogen). Sequencing analysis for white
colonies was carried out, and the sequences between linkers were
analyzed to identify miRNAs, as described below.
Computational analysis
To identify miRNAs, retrieved sequences were searched in the
miRBase (Release 16.0; http://microrna.sanger.ac.uk/) (Ambros et al.,
2003; Grifﬁths-Jones, 2004; Grifﬁths-Jones et al., 2006; Grifﬁths-Jones
et al., 2008). If sequences showed no match to any registered miRNAs,
further analyses were performed to determine whether the sequences
were novel miRNA candidates. The genomic positions in the mouse and
the corresponding sequences in each genome for various animals were
identiﬁed by using the University of California, Santa Cruz (UCSC) web
site (http://genome.ucsc.edu/). Putative secondary structures were
predicted using two RNA fold programs, mfold (http://frontend.bioinfo.
rpi.edu/applications/mfold/cgi-bin/rna-forml.cgi) (Zuker, 2003)andCen-
troidFold (http://www.ncrna.org/centroidfold/) (Hamada et al., 2009).
Unknown small RNAs can be registered as novel miRNAs at miRBase.
Real-time reverse transcription-PCR for miRNA quantiﬁcation
Reverse transcription of miRNAs was carried out using a TaqMan
MicroRNA Reverse Transcription Kit (Applied Biosystems, 1997).
Real-time reverse transcription-PCR (RT-PCR) assays were performed
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microRNA assays (Applied Biosystems, 1997) were used for relative
quantiﬁcation of miRNAs (i.e. miR-199b/199a-3p, miR-125b-5p, miR-
214, and miR-21). The expression levels of these miRNAs were
normalized to snoRNA202, and determined by the comparative Ct
method (Applied Biosystems User Bulletin). Real-time RT-PCR was
performed under the following conditions: 95 °C for 10 min and
40 cycles of 95 °C for 10 s and 60 °C for 1 min. Assays were performed
using a total sample volume of 20 μl per RT reaction, including 6 μl of
complementary DNA (cDNA) derived from 10 ng of small RNA.
Real-time RT-PCR for messenger RNA quantiﬁcation
Total RNAs from SMG rudiments were treated with DNase I
(Invitrogen) and subjected to the reverse-transcription reaction by
superscript II (Invitrogen) with random hexamers to generate cDNA.
Real-time RT-PCR with SYBR green assay was performed in a total
volume of 25 μl per RT reaction, including 1 μl of cDNA derived from
50 ng of total RNA. Assays were performed under the following
conditions: 95 °C for 5 min, and 40 cycles of 95 °C for 15 s and 60 °C
for 1 min using iQ SYBR Green Supermix (Bio-Rad Laboratories). The
melting curve data were collected by increasing the temperature from
60 °C to 95 °C after 2 cycles in increments of 0.5 °C.
Speciﬁc primers for messenger RNAs (mRNAs), serine peptidase
inhibitor (Maspin;NM_009257), nuclear factor I/B (Nﬁb;NM_001113209),
programmed cell death 4 (Pdcd4; NM_011050), reversion-inducing-
cysteine-rich protein with kazal motifs (Reck; NM_016678), sprouty
homolog 2 (Spry2; NM_011897) and ribosomal protein S29 (Rps29;
NM_009093), were designed for SYBR green assay with DNASIS Pro
version 2.08 (HITACHI) and had the following sequences: Maspin
(5′-GGCCAATGCCAAAGTCAAAC-3′ and 5′-TTCAGCCCTAGGCTTTC-
CAG-3′), Nﬁb (5′-CCGGGAAAGTGCGTTTTAAG-3′ and 5′-TGCCTCAA-
TAAATGGGTGGA-3′), Pdcd4 (5′-TTGCTAGATAGGCGGTCCAG-3′ and
5′-TCACATCCACCTCTTCCACA-3′), Reck (5′-TCTCACACTTGGGCCTCTCA-3′
and 5′-ACACGGCAGGCATGACATAG-3′), Spry2 (5′-ATTCAAGGGA-
GAGGGGTTGG-3′ and 5′-TCCATCAGGTCTTGGCAGTG-3′) and Rps29 (5′-
CGGTCTGATCCGCAAATACG-3′ and 5′-TCCATTCAAGGTCGCTTAGTCC-3′).
Each primer set was designed to have a size of about 100 bp and span an
exon/intron junction to avoid ampliﬁcation of genomic DNA. Expression
levels of mRNAs were normalized to Rsp29 (Rebustini and Hoffman,
2009).
This study was approved by the Ethics Committee of Asahi
University School of Dentistry (No. 07–004).
Results and discussion
MiRNAs in native E13 SMG
Cloning analysis revealed the presence of various miRNAs
expressed in native SMGs at E13 (Table 1), including 44 miRNAsTable 1
List of miRNAs detected in murine submandibular gland at embryoni
miRNA
miR-199b/199a-3p
miR-125b-5p
miR-214
miR-16, miR-19b, miR-503, miR-667, let-7a
miR-17, miR-23a, miR-26a, miR-30c, miR-99a, miR-126-3p, miR-19
miR-200b, miR-214*, miR-335-5p
let-7e, let-7g, let-7i, miR-21, miR-22, miR-29b, miR-106b*, miR-107
miR-127, miR-154, miR-181a-2*, miR-199b*, miR-200c, miR-205
miR-322*, miR-379, miR-411, miR-411*, miR-431, miR-466c-5p,
miR-500, miR-532-3p, miR-652
Novel miRNA candidatescomposed of 98 clones, and four previously unidentiﬁed small RNAs
that had nomatch in themiRNA database (miRBase Release 16.0). The
number of sequence reads for a particular miRNA is known to be
proportional to its molecular abundance (Landgraf et al., 2007).
Analysis revealed that miR-199b/199a-3p appeared most frequently
among the total miRNAs in this clone library. miR-199b and miR-
199a-3p are identical in mature sequence, and in this study they are
referred to as miR-199b/199a-3p. Eighteen miRNAs were detected as
multiple clones (Table 1). The relative cloning frequencies of these
miRNAs probably reﬂect their respective levels of expression.
Therefore, it is possible that the expression levels of these miRNAs
are higher than the expression levels of the 26 miRNAs detected as
single clones (Table 1).
Novel miRNA candidates
We obtained four clones which did not match any sequences in
miRBase Release 16.0 (Table 1). These small RNA sequences were
compared with the nucleotide database by NCBI Blast search (http://
blast.ncbi.nlm.nih.gov/Blast.cgi). The secondary structures of the four
sequences were predicted by two programs, mfold (Zuker, 2003) and
CentroidFold (Hamada et al., 2009). Only one hairpin structure met
the criteria for miRNAs using the two programs (Fig. 1A). This clone
sequence, SMG-sRNA-1 (AB597295), was encoded on the 3′ untrans-
lated region (genomic context; 19:6904407-6904430[−]) of Rps6Ka4
(AF074714). The regions of the mature sequence and hairpin
structure were mostly phylogenetically conserved (Fig. 1B). The
alterations in the seed region between rodents and anthropoids
suggest that the target mRNAs are different among these species
(Fig. 1C). Taken together, we identiﬁed this clone sequence, SMG-
sRNA-1, as a novel miRNA (named asmmu-mir-5046 bymiRBase). On
the other hand, three of four sequences, registered as AB597296–
AB597298, did not form a signiﬁcant hairpin structure. However,
considering that those three sequences were obtained by Ago2
immunoprecipitation, they are probably functional small RNA like
endogenous short interfering RNAs (Siomi and Siomi, 2009), which
suggests that they were related to RNA silencing in SMG.
Relative spatial localization of miRNAs
Three miRNAs, miR-199b/199a-3p, miR-125b-5p and miR-214,
showed relatively high cloning frequencies, indicating that their
expression levels were high in E13 SMGs. The relative spatial
localization of the three miRNAs was investigated using epithelium
and mesenchyme separated from E13 SMGs as described in Materials
andmethods (Fig. 2A). For each tissue, the expression levels of the above
three miRNAs were analyzed by real-time RT-PCR (Fig. 2B). The spatial
expressions of all threemiRNAswere higher in themesenchyme than in
the epithelium, suggesting that miRNAswith relatively high expression
levels are distributed mainly in the mesenchyme of E13 SMGs.c day 13.
Number of clones
27
6
4
3
9a-5p, 2
, miR-125a-5p,
, miR-301b,
miR-484,
1
4
Total 102
Fig. 1. Novel miRNA discovered in a submandibular gland at embryonic day 13. (A) Putative secondary structure of the novel miRNA. Two RNA fold programs, mfold (upper) and
CentroidFold (lower), were used to predict the secondary structure. (B) The putative secondary structure is phylogenetically conserved. (C) Alignments of sequences corresponding
to the novel miRNA are shown for various animal species. Nucleotides differing from those of mice are shown in white. Corresponding sequences, except for mice, were extracted
from each genome at the University of California, Santa Cruz [web site (http://genome.ucsc.edu/)]. Human, Homo sapiens; orangutan, Pongo pygmaeus abelii; mouse,Mus musculus;
rat, Rattus norvegicus; dog, Canis lupus familiaris; horse, Equus caballus.
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miR-21 was detected as just one clone in the clone library derived
from SMG at E13 (Table 1). miR-21 is perfectly conserved in mammals
and is one of themost studiedmiRNAs (Krichevsky andGabriely, 2009).
This miR-21 has been especially associated with cancer, because up-
regulation of its expression was found in various tumors (Krichevsky
and Gabriely, 2009). In addition, it was reported that there was a
relationshipbetween regulation ofmiR-21expressionandEGF signaling
(Fujita et al., 2008; Seike et al., 2009). Therefore, we hypothesized that
EGF treatment of native E13 SMG leads to alteration of the miR-21
expression level, followed by enhancement of branching morphogen-
esis. To test this hypothesis, relative quantiﬁcation of the miR-21
expression level was performed by real-time RT-PCR of E13 SMGs with
andwithoutEGF treatment. Exposure to EGF for 24 h resulted in 3.8-fold
up-regulation of miR-21 expression (Pb0.01, one-tailed t-test) (Fig. 3),
which represented a signiﬁcant 1.4-fold increase compared to SMG
without EGF treatment (Pb0.01, one-tailed t-test). These results
indicate that miR-21 expression is endogenously up-regulated during
culture of E13 SMG and is enhanced by EGF treatment.
Furthermore, in order to characterize which tissue, epithelium or
mesenchyme, responds to EGF treatment and leads to miR-21 up-
regulation, E13SMGswere cultured for 24 h and then separated into the
epithelium and mesenchyme (Fig. 4A). The miR-21 expression level in
each tissue was analyzed by real-time RT-PCR. Quantitative analysis
showed that miR-21was expressed predominantly in themesenchyme
(Fig. 4B). Up-regulation ofmiR-21was induced in themesenchyme and
enhancedbyEGF treatment, 1.8-fold compared tomesenchymewithout
EGF (Pb0.01, one-tailed t-test) (Fig. 4B). In contrast, the expression level
of miR-125b-5p was unaffected by EGF treatment (Supplementary
Fig. 1A and B), indicating that not all miRNAs were up-regulated by the
addition of EGF. These results showed that miR-21 expression in E13
SMGs was up-regulated during culture and that endogenous miR-21
expression in the mesenchyme was enhanced by EGF.
Branching morphogenesis in SMGs after miR-21 up/down regulation
RNAi methods were applied to E13 SMG cultures to evaluate the
role of miR-21 in branching morphogenesis by counting the numberof end buds (Fig. 5). First, for inhibition of miR-21, preliminary tests of
uptake revealed that Cy3-labeled ssRNAs were distributed mainly in
the mesenchyme (Figs. 5B and D). The signal intensity was weak, but
positive transfection was distinguished from autoﬂuorescence by
SMG (Fig. 5F).
Next, E13 SMGs were transfected with locked nucleic acids (LNA),
LNA-21 and LNA-cont, respectively. In total, transfection was carried
out for 28 SMGs as matched pairs: 14 rudiments for LNA-21 and 14
rudiments for LNA-cont, respectively (Fig. 6A). After culture for 48 h,
the structure of SMG became more complex than that at 24 h because
of a large number of end buds, whichmade accurate counting difﬁcult.
Therefore, the number of epithelial buds at 24 h was counted to
evaluate the inﬂuence of LNA-21 transfection on branching morpho-
genesis. After 24-h culture, there was a signiﬁcant decrease in the bud
number of SMGs transfected with LNA-21 (Pb0.05) (Fig. 7). As a
control, SMGs were treated with transfection reagent only (RNA(−);
Fig. 6B). The number of buds after 24 h of culture was compared with
SMG cultured in plain medium (without any RNA or transfection
reagent), but there was no signiﬁcant difference between the results
(P=0.42N0.05; data not shown). Taken together, these results
indicate that down-regulation of miR-21 in the mesenchyme leads
to a decrease in the number of epithelial buds.
Preliminary tests of uptake revealed that Cy3-labeled dsRNAswere
distributed in both the epithelium and mesenchyme (Fig. 8).
Interestingly, their positive signals were quite different in intensity
and distribution from those of ssRNAs, suggesting two possibilities:
there was a difference in the uptake system between ssRNAs and
dsRNAs, or the half-life of dsRNAs in the epithelium was longer than
that of ssRNAs. Next, for enhancement of functional miR-21, SMGs at
E13 were transfected with MIM-21 and MIM-cont. In total, transfec-
tion was carried out for 24 SMGs as matched pairs: 12 rudiments for
MIM-21 and 12 rudiments for MIM-cont, respectively. After culture
for 24 h, the number of epithelial buds was counted to evaluate the
inﬂuence of MIM-21 transfection on branching morphogenesis.
However, there was no signiﬁcant difference in bud number between
SMGs transfected with MIM-21 and MIM-cont (P=0.46N0.05; data
not shown). There is a possibility that MIM-21 was transfected into not
only themesenchyme but also the epithelium (Fig. 8). Considering that
up-regulation of miR-21 occurred only in the mesenchyme (Fig. 4B),
Fig. 2. Relative expression levels of miRNAs (i.e. miR-199b/199a-3p, miR-125b-5p and
miR-214) in the epithelium versus the mesenchyme of E13 SMG, showing their relative
spatial localization. (A) SMG rudiments at E13 were separated into two tissues,
epithelium and mesenchyme, by dispase treatment. (B) Each miRNA expression level
was normalized to snoRNA202. Data are the mean±SE for three independent
experiments. *, Pb0.01, one-tailed t-test. RNA integrity number (RIN)=8.9–9.5. Scale
bar=500 μm.
Fig. 3. Up-regulation of endogenous miR-21 expression level in SMG by epidermal
growth factor (EGF) treatment. SMG rudiments isolated from a mouse at E13 were
cultured for 0 h, 6 h, 12 h and 24 h with and without EGF (i.e. EGF(+) and EGF(−),
respectively; EGF 20 ng ml−1). Expression levels were analyzed by real-time RT-PCR
and normalized to snoRNA202. Data are the mean±SE for three independent
experiments. *, Pb0.01, one-tailed t-test. RIN=8.5–9.3.
303T. Hayashi et al. / Developmental Biology 352 (2011) 299–307enhancement of functional miR-21 in the epithelium might exert no
signiﬁcant effect on the number of end buds. This mechanism remains
to be elucidated.
Prediction of target mRNAs of miR-21
miR-21 in themesenchyme of SMG rudiments regulates branching
morphogenesis. In order to understand this miRNA function in the
mesenchyme, target mRNAs need to be characterized. However,
identiﬁcation of speciﬁc target mRNAs remains a major challenge in
miRNA research (Bartel, 2009; Krichevsky and Gabriely, 2009). Based
on a mutual exclusion model, up-regulation of a miRNA leads todown-regulation of its target mRNAs, and vice versa. Therefore, in the
SMG mesenchyme, an increase in the miR-21 expression level would
lead to a decrease in its target mRNAs' expression levels. Accordingly,
relative quantiﬁcation of target mRNA candidates was performed by
real-time RT-PCR. Earlier reports experimentally validated that ﬁve
mRNAs (i.e. Reck, Pdcd4, Maspin, Nﬁb and Spry2) were targeted by
miR-21 in different cellular contexts (Frankel et al., 2008; Fujita et al.,
2008; Gabriely et al., 2008; Sayed et al., 2008; Zhu et al., 2008). Since
we were unable to design an experiment in which MIM-21 as dsRNAs
was transfected into only the mesenchyme to enhance miR-21
function (Fig. 8), the expression levels of ﬁve target mRNAs were
quantiﬁed in both the epithelium and mesenchyme after 24-h culture
with and without EGF treatment (Fig. 9).
The results showed that the expression levels of two genes, Reck
and Pdcd4, were lower in the mesenchyme separated from SMG that
had been treated with EGF compared with no EGF treatment. Because
their expression levels correlated inversely with the miR-21 level,
repression of Reck and Pdcd4 was probably due to interference by
miR-21. One of the ﬁve genes,Maspin, was deleted from the following
analysis, because it was undetectable in SMG samples (data not
shown). Interestingly, although the two remaining mRNAs, Nﬁb and
Spry2, were also shown to be target genes, their expression levels did
not seem to be in accordance with the mutual exclusion model, which
suggests that miR-21's regulation of its target mRNAs depends on
different cellular contexts (Krichevsky and Gabriely, 2009).
RECK is a membrane-anchored inhibitor of metalloproteinases
(MMPs), and reduction or inactivation of MMPs' expression seems to be
critical for the invasiveness andmetastasis of various cancers (Krichevsky
and Gabriely, 2009). For example, RECK inhibited MMP-9 secretion and
activity andattenuatedmetastasis of lung cancer cells (Chang et al., 2008).
MMPs are a group of peptidases involved in degradation of the
extracellular matrix (ECM) and in many other biological processes
(Holmbeck et al., 1999; Hotary et al., 2000; Page-McCaw et al., 2007;
Rebustini et al., 2009; Sternlicht and Werb, 2001). It has been suggested
that degradation of ECM leads to enhancement of branching
morphogenesis because ECM in the mesenchyme is remodeled
during SMG development, which makes epithelial cells invade,
cleave and growproperly (Bernﬁeld et al., 1984; Hogan, 1999; Hotary
et al., 2000; Patel et al., 2006; Umeda et al., 2001). In SMG, most
MMPs are known to be expressed in the mesenchyme, but MMP2,
MMP14 andMMP15 are expressed in the epithelium (Steinberg et al.,
2005; Rebustini et al., 2009). It is known that epithelial MMP2
Fig. 4. Up-regulation of miR-21 expression levels in the mesenchyme of SMG by epidermal growth factor (EGF) treatment. E13 SMG rudiments were isolated from mice at E13
(Native), and some were cultured for 24 h with and without EGF (i.e. EGF(+) and EGF(−), respectively; EGF 20 ng ml−1). (A) SMG rudiments cultured under each condition were
separated into two tissues, epithelium and mesenchyme, by dispase treatment. Representative SMG rudiments after 24-h culture are shown. (B) miR-21 expression levels were
analyzed by real-time RT-PCR and normalized to snoRNA202. Data are the mean±SE for three independent experiments. *, Pb0.01, one-tailed t-test. RIN=9.4–10.0. Scale
bar=500 μm.
304 T. Hayashi et al. / Developmental Biology 352 (2011) 299–307inﬂuences collagen IVmetabolism and epithelial proliferation during
branching morphogenesis (Rebustini et al., 2009). In this study,
mesenchymal MMPs including MMP9, appeared to be regulated byFig. 5. Cy3-labeled control single-stranded RNA (ssRNA) was shown to be distributed in th
presence of N-TER Nanoparticle siRNA Transfection System (SIGMA). (A, C, E) Phase-contr
labeled control ssRNAs (20 nM) were transfected into the SMG and mainly distributed in tRECK, because most MMPs and Reck were distributed mainly in the
mesenchyme (Fig. 9; Steinberg et al., 2005). Therefore, inhibition of
Reck by increased miR-21 expression in the mesenchyme mighte mesenchyme of SMG rudiments. E13 SMG rudiments were cultured for 24 h in the
ast images show living glands. (B, D) Fluorescent microscopy images show that Cy3-
he mesenchyme. (F) Autoﬂuorescence is seen. Scale bar=100 μm.
Fig. 6.Mesenchymal miR-21 inhibition by locked nucleic acids (LNA) decreased the number of epithelial buds in SMG rudiments. E13 SMG rudiments were cultured for 48 h under
various conditions: LNA-21 (20 nM), LNA-cont (20 nM), RNA(−) (medium containing transfection reagent without artiﬁcial RNA), and medium (medium without artiﬁcial RNA or
transfection reagent), respectively. (A) Twenty-eight rudiments as 14 matched pairs were cultured in LNA-21 and LNA-cont. (B) Ten rudiments as ﬁve matched pairs were cultured
in RNA(−) and medium.
305T. Hayashi et al. / Developmental Biology 352 (2011) 299–307result in degradation of ECM by MMPs, leading to enhancement of
branching morphogenesis.
PDCD4was initially discovered as a protein encoded by a gene that
is up-regulated in apoptosis, and it was later characterized as a potent
tumor suppressor (Krichevsky and Gabriely, 2009). It was reported
that PDCD4 binds to and inhibits the translation initiation factor,
eukaryotic initiation factor 4a, thereby impacting on protein transla-
tion (Göke et al., 2002; Yang et al., 2003). In addition, PDCD4 was
found to inhibit transcription factors, such as AP-1-mediated trans-
activation (Yang et al., 2001). Interestingly, AP-1 has been implicated
as a direct regulator of MMP activity (Angel et al., 1987). Putative AP-1
binding sites have been identiﬁed on several MMP promoters,
including MMP9 (Benbow and Brinckerhoff, 1997). Furthermore,
AP-1 is one of the major downstream effectors for mitogen-activatedFig. 7. The number of buds at 24 h was decreased signiﬁcantly in SMG rudiments
treated with LNA-21 (20 nM) compared with LNA-cont (20 nM). The number of buds in
LNA-cont represented 100% for normalization. Data are the mean±SE for three
independent experiments. *, Pb0.05, one-tailed t-test. Scale bar=500 μm.protein kinase (MAPK), and it is known that EGF activates the MAPK
pathway (Kashimata and Gresik, 1997; Kajanne et al., 2007; Prenzel
et al., 2001; Yarden and Sliwkowski, 2001; Whitmarsh and Davis,
1996). Recent studies reported that miR-21 promoter has a binding
site for AP-1, and that AP-1 triggers the transcription of primary miR-
21 (Fujita et al., 2008; Krichevsky and Gabriely, 2009). It was thus
reasonable that EGF treatment of SMG enhanced the miR-21
expression level (Figs. 3 and 4). Therefore, in the mesenchyme of
SMG, double-positive feedback may occur according to the following
steps: 1) endogenous miR-21 inhibits PDCD4, a protein that blocks
trans-activation of AP-1; 2) activated AP-1 binds to the transcription
sites of the promoters for miR-21 and MMPs, respectively; and 3)
elevated miR-21 expression promotes the AP-1 activation through
PDCD4 inhibition. Hence, inhibition of PDCD4 bymiR-21 expression in
themesenchymewould result in ECM degradation byMMPs activated
by AP-1.
In Fig. 9, EGF treatment of mesenchyme led to a fold reduction in
the expression levels of the genes, Reck and Pdcd4, targeted by miR-
21. The decrease in the expression levels of each target gene was
relatively modest. However, both genes are related to the regulation
of MMPs activities, as described above. The ﬁndings suggest that the
phenotype was sufﬁciently induced by additive changes in the
expression levels of Reck and Pdcd4, even though each individual
change was relatively modest.
Additionally, based on a mutual exclusionmodel, we hypothesized
that knock-down of miR-21 using LNA would lead to up-regulation of
the target genes, Reck and Pdcd4, in the mesenchyme of SMG. As
expected, the expression levels of both target genes tended to
increase in the mesenchyme treated with LNA-21. Both the Reck
and Pdcd4 expression levels showed 1.4-fold up-regulation, with an
88% decrease in the bud number, comparedwithmesenchyme treated
Fig. 8. Cy3-labeled control double-stranded RNA (dsRNA) was shown to be distributed in both the epithelium and mesenchyme of SMG rudiments. E13 SMG rudiments were
cultured for 24 h in the presence of N-TER Nanoparticle siRNA Transfection System (SIGMA). (A) Phase-contrast images show living glands. (B) Fluorescent microscopy images show
that Cy3-labeled control dsRNAs (20 nM) were transfected into the SMG and distributed in both the epithelium and mesenchyme. Scale bar=100 μm.
306 T. Hayashi et al. / Developmental Biology 352 (2011) 299–307with LNA-cont. These data support our conclusion that miR-21 in the
mesenchyme of SMG targets two genes, Reck and Pdcd4.
Taken together, although the detailed molecular links between
miR-21 and its target mRNAs remain to be identiﬁed, miR-21
expression in the mesenchyme leads to enhancement of branching
morphogenesis through mesenchymal ECM degradation by MMPs
that are activated as a result of inhibition of at least two mRNAs, Reck
and Pdcd4.
Conclusion
We inventoried miRNAs expressed in SMG at E13 and showed that
miR-21 was involved in branching morphogenesis. miR-21 showed
increased expression in the mesenchyme of SMG, and it regulated
branching morphogenesis by inhibition of at least two genes (Reck
and Pdcd4) expressed in the mesenchyme. To date, numerous studies
focused mainly on an isolated epithelium to investigate branching
morphogenesis in SMG (e.g. Rebustini et al., 2009; Onodera et al.,
2010). However, a recent study of SMG development demonstrated
that parasympathetic innervation in the mesenchyme maintainedFig. 9. Changes in the expression levels of target mRNAs ofmiR-21 in two tissues of SMG
treated with epidermal growth factor (EGF). E13 SMG rudiments were cultured for 24 h
with and without EGF (i.e. EGF(+) and EGF(−), respectively; EGF 20 ng ml−1), and
then separated into two tissues, epithelium and mesenchyme, by dispase treatment.
The expression levels of four target mRNA candidates, Reck, Pdcd4, Nﬁb and Spry2, were
analyzed by real-time RT-PCR and normalized to Rsp29. Data are the mean±SE for
three independent experiments. *, Pb0.05, one-tailed t-test. RIN=9.4−10.0.epithelial progenitor cells through the activation of EGF receptor
signaling (Knox et al., 2010). To further elucidate the effects of
interaction between the epithelium and mesenchyme on branching
morphogenesis in SMG, the role of the mesenchyme needs to be
investigated in future studies.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2011.01.030.Acknowledgments
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